| Name | Title | Contact Details |
|---|
Staffing shortage across the healthcare ecosystem is taking its toll on nursing staff and caregivers. In addition, the desire to shift towards home-based care, especially in rural areas, has driven the need for a better remote patient monitoring platform and patient experience. Current solutions lack a frictionless experience for both the patient and clinician, as they often only offer spot checks and require patients to manipulate devices or receive caregiver assistance. This can be problematic for the elderly, cognitively or motor impaired individuals. Neteeras technology addresses these needs with a continuous, contactless, passive vital signs, and bio-data monitoring solution. Our FCC, HIPAA and GDPR compliant solution seamlessly and safely facilitates rapid and accurate remote patient monitoring in real-time. Neteeras sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. Neteeras technology is a maintenance-free, radar-based solution that is non-intrusive as it does not rely on images. We can improve care and ultimately reduce healthcare costs and enable optimal comfort for the patients as their involvement is not required. Neteera was founded in 2015 by a group of hi-tech veteran executives, including Isaac Litman, the CEO of Mobileye (NYSE: MBLY) Aftermarket.
Baldridge Company is a North Platte, NE-based company in the Business Services sector.
Camp Fire is a Wichita Falls, TX-based company in the Business Services sector.
Hand Willingham Bricker and Associates, Inc. is a Elliot Lake, ON-based company in the Business Services sector.
The Chan Zuckerberg Biohub is a nonprofit research center that brings together physicians, scientists, and engineers from Stanford University; the University of California, Berkeley; and the University of California, San Francisco. Working at CZ Biohub are some of the brightest, boldest engineers, data scientists, and biomedical researchers. Together with colleagues at our partner universities, we seek to understand the fundamental mechanisms underlying disease and develop new technologies that will lead to actionable diagnostics and effective therapies.